News
News
- US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA.2 Subvariant
03/25/2022 / 21:04 - GlobeNewswire - Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting
03/21/2022 / 01:00 - GlobeNewswire - CymaBay Announces Appointment of Éric Lefebvre, M.D. to Board of Directors
03/17/2022 / 21:25 - GlobeNewswire - Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
03/17/2022 / 12:08 - GlobeNewswire - Sanofi, GSK to ask for COVID-19 vaccine authorization
02/23/2022 / 12:30 - TeleTrader - GSK: Q4 turnover increases 9% to £9.5B
02/09/2022 / 08:15 - TeleTrader - Europe up in premarket ahead of Germany's trade data
02/09/2022 / 08:01 - TeleTrader - 23andMe Announces Extension of GSK Collaboration and Update on Joint Immuno-oncology Program
01/18/2022 / 12:55 - GlobeNewswire - Unilever says GSK is 'strong fit' after rejected bid
01/17/2022 / 11:49 - TeleTrader - GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19
01/13/2022 / 15:02 - GlobeNewswire
Real-time